Hong Kong dairy company Ausnutria has announced the start of its acquisition of Victorian dairy manufacturer Australian Dairy Park (ADP).
Once the acquisition is complete, Ausnutria will hold all the business of ADP, including the manufacturing, packaging and sale of dairy and milk powder products and related research and development activities, as well as the existing ADP plant and land in Melbourne.
At the same time, Ausnutria will also hold 50 per cent of Oz Farm’s business (a client of ADP), which includes the marketing and distribution of nutrition products and formula milk products in Australia, Singapore and the PRC, and the marketing and exports of any other dairy, honey or other food and health care products.
“Our vision is for Ausnutria to become a high-end nutritional supplements and health services company,” said Yan Weibin, Chairman of Ausnutria.
“The acquisition of ADP and Oz Farm … is the next step of our “Go Global” strategy after planning the construction of our new plant in the Netherlands in 2015, and signing the agreement with Westland, New Zealand’s second-largest dairy cooperative enterprise, to build a new milk powder factory in 2016.
“[The acquisition will allow] us to extend our supply portfolio from the Netherlands and New Zealand to Australia, and complements our existing product portfolio.”
Ausnutria has stated that it will continue to push forward strategic mergers and acquisitions, and will promote in-depth cooperation between the company and external R&D institutions to accumulate technological experience and international operation experience for company development
Source: Food mag
The company expects to eliminate 1.2 billion tons carbon dioxide equivalent of methane emissions by the end of the decade. The company says that it already reduced its methane emissions by around 14% between 2018 and 2020.
The “first-of-its-kind” pilot project will develop and demonstrate an affordable modular bioprocessing system to produce biodegradable bioplastics from food waste diverted from landfills. The three-year grant will test the scalability and feasibility of the conversion on a national and global scale.
Arkeon is allying with specialty mineral giant ICL to support the scaling of its fermentation bioprocess that converts CO2 into the 20 proteinogenic essential amino acids needed in human nutrition. The process, hailed as carbon negative, is based on the use of archaea, a group of microorganisms that naturally feeds off the greenhouse gas.